Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2017 Filed Oct 3, 2017 23:14 UTC |
OBrien Christopher FlintChief Medical Officer
|
SaleCommon Stock | 6,925 | $61.04 | $422,702.00 |
DisclosureSEC source: 0001209191-17-055457 · doc4.xml · nonDerivative · entry 2 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,973 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.93. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 23:14 UTC |
OBrien Christopher FlintChief Medical Officer
|
Exercise / conversionCommon Stock | 6,925 | $8.65 | $59,901.25 |
DisclosureSEC source: 0001209191-17-055457 · doc4.xml · nonDerivative · entry 1 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Gano KyleChief Business Development Off
|
Exercise / conversionStock Option · Derivative | 4,607 | $8.65 Strike: $8.65 | $39,850.55 |
DisclosureSEC source: 0001209191-17-052021 · doc4.xml · derivative · entry 3 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,390 Underlying: Common Stock · 4,607 shares Expires 2023-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted January 10, 2013 and vested monthly over four years. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Gano KyleChief Business Development Off
|
SaleCommon Stock | 4,607 | $60.00 | $276,420.00 |
DisclosureSEC source: 0001209191-17-052021 · doc4.xml · nonDerivative · entry 2 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,246 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Gano KyleChief Business Development Off
|
Exercise / conversionCommon Stock | 4,607 | $8.65 | $39,850.55 |
DisclosureSEC source: 0001209191-17-052021 · doc4.xml · nonDerivative · entry 1 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:59 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 100 | $18.15 Strike: $18.15 | $1,815.00 |
DisclosureSEC source: 0001209191-17-052022 · doc4.xml · derivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,139 Underlying: Common Stock · 100 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents option which vested 1/4 upon anniversary of grant (11/3/2015), thereafter vesting in equal monthly installments over the following three years such that the entire award is fully vested at 11/3/2018. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:59 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 100 | $60.00 | $6,000.00 |
DisclosureSEC source: 0001209191-17-052022 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,157 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:59 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 100 | $18.15 | $1,815.00 |
DisclosureSEC source: 0001209191-17-052022 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 313 | $19.59 Strike: $19.59 | $6,131.67 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · derivative · entry 8 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,665 Underlying: Common Stock · 313 shares Expires 2024-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options granted January 16, 2014 and vests monthly over four years. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 10,937 | $19.59 Strike: $19.59 | $214,255.83 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · derivative · entry 7 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,085 Underlying: Common Stock · 10,937 shares Expires 2024-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options granted January 16, 2014 and vests monthly over four years. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 2,207 | $8.65 Strike: $8.65 | $19,090.55 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · derivative · entry 6 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,830 Underlying: Common Stock · 2,207 shares Expires 2023-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options granted January 10, 2013 and vested monthly over four years. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 12,793 | $8.65 Strike: $8.65 | $110,659.45 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · derivative · entry 5 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,170 Underlying: Common Stock · 12,793 shares Expires 2023-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options granted January 10, 2013 and vested monthly over four years. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
SaleCommon Stock | 11,250 | $60.00 | $675,000.00 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · nonDerivative · entry 4 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,601 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionCommon Stock | 11,250 | $19.59 | $220,387.50 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · nonDerivative · entry 3 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
SaleCommon Stock | 15,000 | $60.00 | $900,000.00 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · nonDerivative · entry 2 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,601 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 18:58 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionCommon Stock | 15,000 | $8.65 | $129,750.00 |
DisclosureSEC source: 0001209191-17-052020 · doc4.xml · nonDerivative · entry 1 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2017 Filed Oct 3, 2017 23:13 UTC |
Gano KyleChief Business Development Off
|
Exercise / conversionStock Option · Derivative | 20,393 | $8.65 Strike: $8.65 | $176,399.45 |
DisclosureSEC source: 0001209191-17-055452 · doc4.xml · derivative · entry 3 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 20,393 shares Expires 2023-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted January 10, 2013 and vested monthly over four years. Read SEC document |
| September 06, 2017 Filed Oct 3, 2017 23:13 UTC |
Gano KyleChief Business Development Off
|
SaleCommon Stock | 20,393 | $60.00 | $1,223,580.00 |
DisclosureSEC source: 0001209191-17-055452 · doc4.xml · nonDerivative · entry 2 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,246 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| September 06, 2017 Filed Oct 3, 2017 23:13 UTC |
Gano KyleChief Business Development Off
|
Exercise / conversionCommon Stock | 20,393 | $8.65 | $176,399.45 |
DisclosureSEC source: 0001209191-17-055452 · doc4.xml · nonDerivative · entry 1 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 21:55 UTC |
OBrien Christopher FlintChief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 52,817 | $8.66 Strike: $8.66 | $457,395.22 |
DisclosureSEC source: 0001209191-17-051944 · doc4.xml · derivative · entry 3 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,299 Underlying: Common Stock · 52,817 shares Expires 2022-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted January 12, 2012 and vested in 36 equal monthly installments. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 21:55 UTC |
OBrien Christopher FlintChief Medical Officer
|
SaleCommon Stock | 52,817 | $57.50 | $3,036,977.50 |
DisclosureSEC source: 0001209191-17-051944 · doc4.xml · nonDerivative · entry 2 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,973 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $57.50 to $57.52. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 21:55 UTC |
OBrien Christopher FlintChief Medical Officer
|
Exercise / conversionCommon Stock | 52,817 | $8.66 | $457,395.22 |
DisclosureSEC source: 0001209191-17-051944 · doc4.xml · nonDerivative · entry 1 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 14, 2017 16:29 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 15,354 | $5.76 Strike: $5.76 | $88,439.04 |
DisclosureSEC source: 0001209191-17-048696 · doc4.xml · derivative · entry 3 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,354 shares Expires 2021-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted August 25, 2011 and vested in 36 equal monthly installments beginning September 25, 2011. Read SEC document |
| August 09, 2017 Filed Aug 14, 2017 16:29 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
SaleCommon Stock | 15,354 | $55.00 | $844,470.00 |
DisclosureSEC source: 0001209191-17-048696 · doc4.xml · nonDerivative · entry 2 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,691 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| August 09, 2017 Filed Aug 14, 2017 16:29 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
Exercise / conversionCommon Stock | 15,354 | $5.76 | $88,439.04 |
DisclosureSEC source: 0001209191-17-048696 · doc4.xml · nonDerivative · entry 1 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 14, 2017 16:30 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 5,000 | $18.15 Strike: $18.15 | $90,750.00 |
DisclosureSEC source: 0001209191-17-048697 · doc4.xml · derivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,239 Underlying: Common Stock · 5,000 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents option which vests 1/4 upon anniversary of grant (11/3/2015), thereafter vesting in equal monthly installments over the following three years such that the entire award is fully vested at 11/3/2018. Read SEC document |
| August 09, 2017 Filed Aug 14, 2017 16:30 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 5,000 | $55.00 | $275,000.00 |
DisclosureSEC source: 0001209191-17-048697 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,157 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| August 09, 2017 Filed Aug 14, 2017 16:30 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 5,000 | $18.15 | $90,750.00 |
DisclosureSEC source: 0001209191-17-048697 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 2,726 | $8.66 Strike: $8.66 | $23,607.16 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · derivative · entry 8 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 2,726 shares Expires 2022-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted January 12, 2012 and vested in 36 equal monthly installments. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionNon Qualified Stock Option · Derivative | 17,274 | $8.66 Strike: $8.66 | $149,592.84 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · derivative · entry 7 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,726 Underlying: Common Stock · 17,274 shares Expires 2022-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted January 12, 2012 and vested in 36 equal monthly installments. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 5,071 | $5.76 Strike: $5.76 | $29,208.96 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · derivative · entry 6 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 5,071 shares Expires 2021-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted August 25, 2011 and vested in 36 equal monthly installments beginning September 25, 2011. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionNon Qualified Stock Option · Derivative | 19,929 | $5.76 Strike: $5.76 | $114,791.04 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · derivative · entry 5 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,071 Underlying: Common Stock · 19,929 shares Expires 2021-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted August 25, 2011 and vested in 36 equal monthly installments beginning September 25, 2011. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
SaleCommon Stock | 20,000 | $50.00 | $1,000,000.00 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · nonDerivative · entry 4 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,601 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.10. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionCommon Stock | 20,000 | $8.66 | $173,200.00 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · nonDerivative · entry 3 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
SaleCommon Stock | 2,500 | $50.00 | $125,000.00 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · nonDerivative · entry 2 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,601 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:44 UTC |
Bozigian Haig P.Chief Development Officer
|
Exercise / conversionCommon Stock | 25,000 | $5.76 | $144,000.00 |
DisclosureSEC source: 0001209191-17-048144 · doc4.xml · nonDerivative · entry 1 Bozigian Haig P. · CIK 0001423837 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 20:29 UTC |
OBrien Christopher FlintChief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 8,734 | $8.65 Strike: $8.65 | $75,549.10 |
DisclosureSEC source: 0001209191-17-046685 · doc4.xml · derivative · entry 3 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,266 Underlying: Common Stock · 8,734 shares Expires 2023-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted January 10, 2013 and vested over 4 years. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 20:29 UTC |
OBrien Christopher FlintChief Medical Officer
|
SaleCommon Stock | 8,734 | $50.00 | $436,700.00 |
DisclosureSEC source: 0001209191-17-046685 · doc4.xml · nonDerivative · entry 2 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,973 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 20:29 UTC |
OBrien Christopher FlintChief Medical Officer
|
Exercise / conversionCommon Stock | 8,734 | $8.65 | $75,549.10 |
DisclosureSEC source: 0001209191-17-046685 · doc4.xml · nonDerivative · entry 1 OBrien Christopher Flint · CIK 0001343124 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:13 UTC |
Grigoriadis Dimitri E.Chief Research Officer
|
SaleCommon Stock | 10,000 | $53.39 | $533,900.00 |
DisclosureSEC source: 0001209191-17-034910 · doc4.xml · nonDerivative · entry 1 Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,691 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $53.01 to $53.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:37 UTC |
SHERWIN STEPHEN ADirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038638 · doc4.xml · derivative · entry 1 SHERWIN STEPHEN A · CIK 0001079462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:36 UTC |
Sandrock AlfredDirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038636 · doc4.xml · derivative · entry 1 Sandrock Alfred · CIK 0001577061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:35 UTC |
RASTETTER WILLIAM HDirector
|
GrantStock Option · Derivative | 18,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038634 · doc4.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:33 UTC |
POPS RICHARD FDirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038633 · doc4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:32 UTC |
Nevinny Corinne HDirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038632 · doc4.xml · derivative · entry 1 Nevinny Corinne H · CIK 0001182467 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:31 UTC |
MORROW GEORGE JDirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038631 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:30 UTC |
MOLLICA JOSEPH ADirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038629 · doc4.xml · derivative · entry 1 MOLLICA JOSEPH A · CIK 0001126489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:29 UTC |
LYONS GARY ADirector
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038628 · doc4.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 19, 2017 Filed May 23, 2017 20:34 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 4,980 | $15.45 Strike: $15.45 | $76,941.00 |
DisclosureSEC source: 0001209191-17-034632 · doc4.xml · derivative · entry 6 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,040 Underlying: Common Stock · 4,980 shares Expires 2024-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents option which vests 1/4 upon anniversary of grant (10/1/2015), thereafter vesting in equal monthly installments over the following three years such that the entire award is fully vested at 10/1/2018. Read SEC document |
| May 19, 2017 Filed May 23, 2017 20:34 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
SaleCommon Stock | 4,980 | $54.00 | $268,920.00 |
DisclosureSEC source: 0001209191-17-034632 · doc4.xml · nonDerivative · entry 4 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,017 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.